Thursday, 11 June
International Conference Centre Sydney
| Pyrmont Theatre |
9.30 am
Session 1
9.30 am
Welcome and introduction
Chair
Professor Michael Kassiou,
The University of Sydney
Panel
Dr Laura Issa, Bespoke Genetic Medicines Inc.
A/Prof Lindsay Wu, Proto Axiom
Dr Phil Kearney, Amaroq Therapeutics
9.35 am
Keynote
Dr Daniel Beard
Senior Lecturer, The University of Newcastle
Co-Founder and CSO of ShearFlow
10.05 am
ShARC Tank Pitch
An effective therapy for cognitive decline and Alzheimer’s Disease
Prof Greg Neely
The University of Sydney
CEO of Enhanced Analgesics
10.30 am
Morning tea
Please note location change to C2.2 after morning tea.
| Room C2.2 |
11.15 am
Session 2
Chair
Dr Sharissa Latham,
Garvan Institute
Panel
Dr Anand Gautam, G2ome Consulting
Dr Maria Lund, IP Group
Chris Alma, Biotech Industry Executive
11.15 am
Pitch
Microbiome-Derived Protein Therapeutics for Colorectal Cancer
Dr Howard Yim
UNSW
11.40 am
Pitch
Fail faster, Succeed smarter:
real-time on-target validation in drug development
Prof Mathias Francois
The University of Sydney
12.05 am
Sponsor presentation
Dr Heather Donaghy
Scientific Engagement Manager, Cell and Gene Therapies
Therapeutic Innovation Australia
12.15 pm
Lunch
1.30 pm
Session 3
Chair
Dr Aster Pijning
Centenary Institute
Panel
Leah Goodman, Biointelect
Dr Prashanth Rajan, Brandon Capital
Prof Paul Young, ABINITIO
1.30 pm
Fireside chat
In conversation with
Prof Michael Kassiou and Dr Aster Pijning
Dr Alan Taylor
Executive Chairperson
Clarity Pharmaceuticals
2.15 pm
Pitch
OptoSleep–
A revolutionary new therapy for Obstructive Sleep Apnoea
Dr Fiona Knapman
UNSW
2.55 pm
Session 4
Chair
Dr Aidan Grosas
University of Wollongong
Panel
Prof Brendon Monahan, MedChem Australia
Dr Mike Lamprecht, Tenmile
Dr Laura Issa, Bespoke Genetic Medicines Inc.
2.55 pm
Pitch
On demand gene therapies for dementia
Dr Magdalena Przybyla
Macquarie University
3.20 pm
Pitch
Small molecule for the discovery of Niemann-Pick Type C disease
Dr Janney Wang
The University of Sydney
3.45 pm
Afternoon tea
4.30 pm
Session 5
Chair
Dr Kirsten Coupland
University of Newcastle
Panel
Kathy Connell, Avecho
Dr Phil Kearney, Amaroq Therapeutics
Dr Wolfgang Jarolimek, Syntara
4.30 pm
Pitch
Targeting histone H3 supply in epigenetically addicted cancers
Dr Jean Bertoldo
Children’s Cancer Institute
4.55 pm
Pitch
Transforming glioblastoma treatment through
targeted gene delivery and blood-brain barrier modulation
Dr Guoying Wang
Macquarie University
5.20 pm
Best speaker awards
5.30 pm
Close
